|
|
Hormone treatment and timing relative to inducing event
|
|
| Species |
Treatment or Mutation* |
Before |
Immediately After |
After a Delay |
References |
|
| Rat |
Hexanedione* |
|
GnRH-agonist |
GnRH-agonist |
(Blanchard et al, 1998) |
| Rat |
Radiation (gamma)* |
T+E2 |
GnRH-agonist, GnRH-antagonist, testosterone |
GnRH-agonist, GnRH-antagonist, testosterone, androgens |
(Meistrich and Kangasniemi,
1997; Meistrich et al,
2000,
2001b;
Shetty et al, 2000;
Shetty et al, 2002) |
| Rat |
Procarbazine* |
GnRH-agonist + flutamide, GnRH-antagonist + flutamide, T, T+E2 |
GnRH-agonist |
|
(Parchuri et al, 1993;
Kangasniemi et al,
1995a,b;
Meistrich, 1999) |
| Rat |
Indenopyridine (CDB-4022)* |
GnRH-agonist |
GnRH-agonist |
|
(Hild et al, 2001) |
|
|
GnRH-antagonist |
{GnRH-antagonist} |
|
S.A. Hild, personal communication |
| Rat |
DBCP* |
|
GnRH-agonist |
GnRH-agonist |
M.L. Meistrich, unpublished |
| Rat |
Acute heating |
GnRH-agonist + flutamide |
GnRH-agonist + flutamide |
|
(Setchell et al, 2001) |
| Rat |
Aging* |
|
|
GnRH-agonist (at 27 mo) |
(Schoenfeld et al, 2001) |
| Rat |
Busulfan |
{GnRH-agonist} |
GnRH-agonist |
|
(Udagawa et al, 2001) |
| Rat |
Busulfan, spermatogonial transplant |
GnRH-agonist |
GnRH-agonist |
|
(Ogawa et al, 1999) |
| Mouse |
jsd mutation* |
|
GnRH-antagonist (at age 5 weeks) |
GnRH-antagonist (at age 10 weeks) |
(Matsumiya et al, 1999;
Shetty et al, 2001) |
| Mouse |
Busulfan, spermatogonial transplant |
GnRH-agonist |
{GnRH-agonist} |
|
(Ogawa et al, 1998;
Dobrinski et al, 2001) |
|
| *Instances in which it has been shown that type A spermatogonia are present in
the atrophic tubules but do not undergo differentiation. |
Hormone treatment was given both before and after the toxicant
treatment. |
The hormone in brackets {hormone} indicates the treatment was tried
but was unsuccessful. |
|